Uncontrolled EGFR activity (by overexpression or structural abnormalities in the receptor or its ligands) has been implicated in many aspects of tumour growth, including the promotion of cell proliferation, angiogenesis, invasion, metastasis and survival. Here, EGFR is linked to neoplasm.